Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study was designed to investigate the efficacy and safety of NVA237, a long-acting
muscarinic antagonist, in patients with moderate to severe COPD.